• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER HEALTHCARE LLC, CONSUMER CARE ALEVE DIRECT THERAPY TENS STIMULATOR, NERVE, TRANSCUTANEOUS, ELECTRICAL NERVE STIMULATOR (TENS)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER HEALTHCARE LLC, CONSUMER CARE ALEVE DIRECT THERAPY TENS STIMULATOR, NERVE, TRANSCUTANEOUS, ELECTRICAL NERVE STIMULATOR (TENS) Back to Search Results
Model Number N/A
Device Problem Inappropriate/Inadequate Shock/Stimulation (1574)
Patient Problems Skin Discoloration (2074); Electric Shock (2554)
Event Type  malfunction  
Event Description
This spontaneous case was reported by a consumer and describes the occurrence of medical device site discolouration ("leaves marks on my back where it shocks") in an elderly female patient who received aleve tens device direct therapy unit (udi no. (b)(4)). Other product or product use issues identified: device stimulation issue "this device literally shocks me. " (seriousness criterion medically significant). On an unknown date, the patient started aleve tens device direct therapy unit. On an unknown date, the patient experienced medical device site discolouration. It was unknown whether any action was taken with aleve tens device direct therapy unit. At the time of the report, the medical device site discolouration outcome was unknown. The reporter provided no causality assessment for medical device site discolouration with aleve tens device direct therapy unit. Quality-safety evaluation of ptc: based on the technical investigation, a review of the device history for this serial number was conducted and no defects were identified during the manufacture of the device. This product technical complaint cannot be confirmed at this time. No product was returned. Good faith attempts were made to retrieve the product and/or obtain product information however no further information could be obtained. All aleve direct therapy tens units and gelpads are made in accordance with current good manufacturing practices and to the applicable fda and iso regulations. All product undergoes 100% inspection and 100% functional testing at multiple points throughout the manufacturing process where the associated data and documentation is reviewed to ensure all released product meets product specifications. The ptc investigation was initiated and the outcome of the investigation resulted in an unconfirmed quality defect. Further company follow-up with the consumer is not possible. Most recent follow-up information incorporated above includes: on 16-may-2018: quality-safety evaluation of ptc was received. This spontaneous report refers to an elderly female patient who used aleve tens device direct therapy unit (transcutaneous electrical nerve stimulation (tens therapy)) (dates of use and indication were not provided). Patient informed: "this device literally shocks me (interpreted as electric shock), leaves marks on my back where it shocks (associated non-serious event since there was no further diagnosis regarding the marks). " this device literally shocks me was considered serious, in a conservative approach, since it could have cause a permanent damage to the body. The events are unlisted according to aleve tens reference safety information. Considering the mechanisms of action of suspect product, the close temporal relationship and the nature of reported event, company does not exclude an association between reported event and aleve tens device direct therapy unit. No further information is expected from the reporter. The ptc investigation was initiated and the outcome of the investigation resulted in an unconfirmed quality defect. No further information is expected. This case was regarded as incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameALEVE DIRECT THERAPY TENS
Type of DeviceSTIMULATOR, NERVE, TRANSCUTANEOUS, ELECTRICAL NERVE STIMULATOR (TENS)
Manufacturer (Section D)
BAYER HEALTHCARE LLC, CONSUMER CARE
36 columbia rd.
morristown NJ 07960
Manufacturer (Section G)
BAYER HEALTHCARE LLC, CONSUMER CARE
36 columbia rd.
morristown NJ 07960
Manufacturer Contact
k. shaw lamberson
100 bayer blvd.
p.o. box 915
whippany 07981-0915
MDR Report Key7525729
MDR Text Key108996320
Report Number2248903-2018-00002
Device Sequence Number1
Product Code NUH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K152852
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Reporter Occupation
Type of Report Initial
Report Date 05/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator
Device Model NumberN/A
Was Device Available for Evaluation? No Answer Provided
Is the Reporter a Health Professional?
Was the Report Sent to FDA? No
Event Location No Information
Date Manufacturer Received04/23/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device?
Type of Device Usage Reuse

Patient Treatment Data
Date Received: 05/18/2018 Patient Sequence Number: 1
-
-